KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Deferred Revenue (2020 - 2025)

Pfizer (PFE) has disclosed Current Deferred Revenue for 6 consecutive years, with $784.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 48.11% to $784.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $784.0 million, a 48.11% decrease, with the full-year FY2025 number at $784.0 million, down 48.11% from a year prior.
  • Current Deferred Revenue was $784.0 million for Q4 2025 at Pfizer, down from $924.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $6.2 billion in Q4 2022 to a low of $784.0 million in Q4 2025.
  • A 5-year average of $2.4 billion and a median of $2.4 billion in 2023 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: surged 175.56% in 2021, then plummeted 66.19% in 2023.
  • Pfizer's Current Deferred Revenue stood at $3.1 billion in 2021, then fell by 17.84% to $2.5 billion in 2022, then increased by 7.14% to $2.7 billion in 2023, then tumbled by 44.04% to $1.5 billion in 2024, then plummeted by 48.11% to $784.0 million in 2025.
  • Per Business Quant, the three most recent readings for PFE's Current Deferred Revenue are $784.0 million (Q4 2025), $924.0 million (Q3 2025), and $1.1 billion (Q2 2025).